New market rumors about Basilea Pharmaceutica

Swiss daily Neue Zürcher Zeitung reported today that Switzerland-based Basilea Pharmaceutica has become an acquisition target in big pharma. The company has currently a market capitalization of approximately CHF874m.
(Source Neue Zürcher Zeitung)